2017
DOI: 10.1016/j.ejps.2017.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Oral delivery of vancomycin by tetraether lipid liposomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1
1

Relationship

5
5

Authors

Journals

citations
Cited by 74 publications
(40 citation statements)
references
References 32 publications
1
38
0
1
Order By: Relevance
“…In an attempt to enhance the stabilization of orally administered peptide antibiotics, vancomycin was encapsulated within liposomes containing specific tetra ether lipid. The results of in vivo study on Wistar rats expressed a strong enhancement in the oral bioavailability of vancomycin using the liposomal formulation (4.82 ± 0.56%), where the given oral dose of vancomycin reached the blood after one hour, which is considered a very good achievement for the oral administration of peptide antibiotics [41]. Further, administrations of either dicloxacillin-loaded liposomes or dicloxacillin-loaded chitosan-coated liposomes were evaluated against MRSA infections.…”
Section: -Better Protection and Enhanced Antibiotics Biodistributionmentioning
confidence: 99%
“…In an attempt to enhance the stabilization of orally administered peptide antibiotics, vancomycin was encapsulated within liposomes containing specific tetra ether lipid. The results of in vivo study on Wistar rats expressed a strong enhancement in the oral bioavailability of vancomycin using the liposomal formulation (4.82 ± 0.56%), where the given oral dose of vancomycin reached the blood after one hour, which is considered a very good achievement for the oral administration of peptide antibiotics [41]. Further, administrations of either dicloxacillin-loaded liposomes or dicloxacillin-loaded chitosan-coated liposomes were evaluated against MRSA infections.…”
Section: -Better Protection and Enhanced Antibiotics Biodistributionmentioning
confidence: 99%
“…Some of the presented compounds have already been tested on vancomycin-intermediate S. aureus strains, with promising results (Blaskovich et al 2018;Yarlagadda et al 2014Yarlagadda et al , 2016Guan et al 2019). However, vancomycin is still considered to be the gold standard for the therapy of susceptible representatives of this species (Uhl et al 2017). Furthermore, it was already approved for therapeutic treatment of infections with Clostridium difficile (Bartlett 2008).…”
Section: Counteracting Strategiesmentioning
confidence: 99%
“…It is critical to accurately characterize liposomes and drug-liposome interactions as biophysical properties of liposomes are known to influence biological activity, biodistribution, and toxicity. Among the available techniques (Dynamic Light Scattering (DLS), Size Exclusion Chromatography (SEC), Atomic Force Microscopy (AFM), and cryo-EM), cryo-EM is the most precise and direct method to determine liposome lamellarity, size, shape and ultrastructure, which may reveal clues to mechanism of action toward the clinical endpoints of efficacy and toxicity (Aissaoui et al, 2011;Al-Ahmady et al, 2016;Baxa, 2018;Bonnaud et al, 2013;Crawford et al, 2011;De Carlo et al, 2004;Lepault et al, 1985;Uhl et al, 2017;Uhl et al, 2016;Zhang et al, 2013).…”
Section: Introductionmentioning
confidence: 99%